ZANGRILLI, ARIANNA
 Distribuzione geografica
Continente #
NA - Nord America 5.451
EU - Europa 510
AS - Asia 382
SA - Sud America 35
AF - Africa 8
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.392
Nazione #
US - Stati Uniti d'America 5.446
SG - Singapore 164
CN - Cina 107
IE - Irlanda 89
DE - Germania 80
IT - Italia 71
SE - Svezia 67
RU - Federazione Russa 55
UA - Ucraina 52
HK - Hong Kong 49
FR - Francia 36
GB - Regno Unito 34
BR - Brasile 31
KR - Corea 17
UZ - Uzbekistan 12
FI - Finlandia 11
IN - India 8
KG - Kirghizistan 7
AU - Australia 5
NL - Olanda 5
CA - Canada 4
BE - Belgio 3
RO - Romania 3
AR - Argentina 2
CH - Svizzera 2
EG - Egitto 2
ID - Indonesia 2
IQ - Iraq 2
MA - Marocco 2
MY - Malesia 2
TR - Turchia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
DZ - Algeria 1
EU - Europa 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
KE - Kenya 1
KH - Cambogia 1
MD - Moldavia 1
MX - Messico 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PS - Palestinian Territory 1
VE - Venezuela 1
Totale 6.392
Città #
Wilmington 1.582
Houston 1.274
Woodbridge 1.155
Fairfield 236
Chandler 199
Singapore 126
Ashburn 123
Ann Arbor 109
Seattle 96
Cambridge 88
Dublin 84
Medford 62
Dearborn 46
Hong Kong 46
Jacksonville 43
Lawrence 29
Beijing 28
New York 25
The Dalles 25
Santa Clara 24
Rome 19
Zhengzhou 18
San Diego 17
Council Bluffs 15
Moscow 13
Shanghai 11
Munich 10
Boardman 9
Hefei 8
Seoul 8
Menlo Park 7
Norwalk 7
Redmond 7
Redwood City 7
Bologna 5
Esslingen am Neckar 5
Jinan 4
Kilburn 4
Nanjing 4
Palo Alto 4
Sedico 4
Sydney 4
Augusta 3
Brasília 3
Brussels 3
Detroit 3
Genazzano 3
Guangzhou 3
London 3
Mülheim 3
Nanchang 3
Paris 3
Aprilia 2
Atlanta 2
Bari 2
Belo Horizonte 2
Cairo 2
Central 2
Coimbatore 2
Engelhard 2
Falls Church 2
Fuzhou 2
Giugliano In Campania 2
Guidonia 2
Hebei 2
Jakarta 2
Joliet 2
Kunming 2
Milan 2
Mugnano di Napoli 2
Nürnberg 2
Pisa 2
Pune 2
Saint Petersburg 2
San Francisco 2
Shenyang 2
Stockertown 2
Stockport 2
Suceava 2
Sundern 2
Toronto 2
Wuhan 2
Xi'an 2
Acton 1
Albano Laziale 1
Ankara 1
Araxá 1
Ardabil 1
Arenápolis 1
Arequipa 1
Auburn Hills 1
Bellingham 1
Blida 1
Boston 1
Büdelsdorf 1
Cabo Frio 1
Cape Town 1
Carapicuíba 1
Casablanca 1
Chengdu 1
Totale 5.699
Nome #
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 425
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 402
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 395
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. 393
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 392
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 358
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 356
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 354
Erysipeloid cutaneous metastasis from bladder carcinoma 347
Long-term treatment of psoriatic patients with adalimumab reduces disease severity and maintains a favorable lipid pattern and a low Atherogenic Index. 324
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 304
Radiologically significant joint improvement in a patient affected by psoriatic arthritis treated with adalimumab 285
Paradoxical case effects of psoriasis following adalimumab therapy: A case series 234
Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice 231
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation 212
One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast 211
Real life experience of apremilast in psoriasis and arthritis psoriatic patients: preliminary results on metabolic biomarkers 160
Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation 157
Efficacy and safety of Adalimumab in difficult-to-treat psoriasis 151
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 122
Ixekizumab: One drug for an enigmatic psoriasis 106
Psoriasis in difficult to treat areas: treatment role in improving health-related quality of life and perception of the disease stigma 100
Omalizumab and adalimumab: a winning couple 93
A linear forehead lesion caused by intralesional injection of triamcinolone acetonide and treated with hyaluronic acid filler: case report 81
Adalimumab for moderate to severe psoriasis: an open-label, retrospective 3-year study 80
Risankizumab: How to choose the right dose in clinical practice? 70
Paradoxical psoriasis induced by anti-TNFα treatment: evaluation of disease-specific clinical and genetic markers 66
Long-term efficacy of adalimumab in generalized pustular psoriasis 59
Clinical severity instruments 55
Effectiveness of risankizumab for the treatment of psoriatic arthritis: a multicenter, real‐world study 23
Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: A 52-week Italian real-life experience 17
Improvement of Psoriasis Using Oral Probiotic Streptococcus salivarius K-12: a Case–Control 24-Month Longitudinal Study 16
Effectiveness of ixekizumab in elderly patients for the treatment of moderate-to-severe psoriasis: results from a multicenter, retrospective real-life study in the Lazio region 8
null 3
Totale 6.590
Categoria #
all - tutte 17.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.546


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020429 0 0 0 0 0 0 0 0 0 188 113 128
2020/20211.380 108 124 116 155 204 191 176 159 44 44 36 23
2021/2022333 17 31 21 26 10 18 18 13 18 51 20 90
2022/2023456 36 51 24 54 38 98 38 23 49 13 18 14
2023/2024150 15 3 8 5 19 29 12 23 4 9 0 23
2024/2025476 28 119 93 28 6 36 68 31 52 15 0 0
Totale 6.590